A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 406,723 shares of ABT stock, worth $46.7 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
406,723
Previous 401,705 1.25%
Holding current value
$46.7 Million
Previous $41.7 Million 11.09%
% of portfolio
2.46%
Previous 2.37%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $502,151 - $592,776
5,018 Added 1.25%
406,723 $46.4 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $556,734 - $621,455
5,527 Added 1.4%
401,705 $41.7 Million
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $1.12 Million - $1.24 Million
10,213 Added 2.65%
396,178 $45 Million
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $134,563 - $164,716
-1,492 Reduced 0.39%
385,965 $42.5 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $376,006 - $451,144
3,936 Added 1.03%
387,457 $37.5 Million
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $178,380 - $198,753
-1,770 Reduced 0.46%
383,521 $41.8 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $285,543 - $336,101
-2,948 Reduced 0.76%
385,291 $39 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $403,624 - $473,513
-4,246 Reduced 1.08%
388,239 $42.6 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $219,645 - $254,308
2,270 Added 0.58%
392,485 $38 Million
Q2 2022

Aug 05, 2022

SELL
$102.07 - $123.37 $191,789 - $231,812
-1,879 Reduced 0.48%
390,215 $42.4 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $8,779 - $10,706
77 Added 0.02%
392,094 $46.4 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $113,450 - $138,913
982 Added 0.25%
392,017 $55.2 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $872,266 - $964,981
7,477 Added 1.95%
391,035 $46.2 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $398,193 - $468,730
3,764 Added 0.99%
383,558 $44.5 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $69,331 - $81,682
637 Added 0.17%
379,794 $45.5 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $700,350 - $763,181
6,670 Added 1.79%
379,157 $41.5 Million
Q3 2020

Oct 28, 2020

BUY
$91.64 - $111.29 $1.5 Million - $1.82 Million
16,358 Added 4.59%
372,487 $40.5 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $1.4 Million - $1.79 Million
18,313 Added 5.42%
356,129 $32.6 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $403,304 - $589,741
6,420 Added 1.94%
337,816 $26.7 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $1.67 Million - $1.85 Million
21,211 Added 6.84%
331,396 $28.8 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $371,062 - $402,347
4,534 Added 1.48%
310,185 $26 Million
Q2 2019

Aug 06, 2019

SELL
$72.88 - $85.0 $430,210 - $501,755
-5,903 Reduced 1.89%
305,651 $25.7 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $608,561 - $735,751
9,190 Added 3.04%
311,554 $24.9 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $205,792 - $233,133
3,139 Added 1.05%
302,364 $21.9 Million
Q3 2018

Nov 26, 2018

BUY
$60.81 - $73.36 $561,033 - $676,819
9,226 Added 3.18%
299,225 $22 Million
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $648,410 - $715,651
11,263 Added 4.04%
289,999 $17.7 Million
Q1 2018

Jul 26, 2018

BUY
$56.27 - $63.62 $14.7 Million - $16.7 Million
262,034 Added 1568.88%
278,736 $16.7 Million
Q1 2018

May 03, 2018

SELL
$56.27 - $63.62 $14.1 Million - $15.9 Million
-250,072 Reduced 93.74%
16,702 $279 Million
Q4 2017

Feb 06, 2018

BUY
$53.68 - $57.47 $82,076 - $87,871
1,529 Added 0.58%
266,774 $0
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $440,662 - $491,825
9,169 Added 3.58%
265,245 $14.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
256,076
256,076 $12.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.